Carlos Doti

Carlos Doti is currently the Vice President of US Medical Affairs Oncology at AstraZeneca, a role they have held since 2022. Previously, Carlos served in various leadership positions within AstraZeneca, including as the Global Medical Affairs Head of Hematology and interim United States Hematology Franchise Head for Medical Affairs. Carlos also worked as a Regional Medical Director for Oncology at Pfizer and has extensive experience in hematology through roles at Hospital Britanico de Buenos Aires, where they were an attending physician, and at the Sociedad Argentina de Hematología. They earned their MD in Medicine with a specialization in Hematology from the University of Buenos Aires.